Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia

被引：0

作者：

Tiribelli, Mario ^{[1
,2
,3
]}

Toffoletti, Eleonora ^{[1
,2
]}

Di Giusto, Sara ^{[1
]}

Fanin, Renato ^{[1
,2
]}

Damiani, Daniela ^{[1
,2
]}

机构：

[1] Azienda Sanit Univ Friuli Cent, Div Hematol & Bone Marrow Transplantat, Udine, Italy

[2] Univ Udine, Dept Med Area, Udine, Italy

[3] Osped SM Misericordia, Div Hematol & Bone Marrow Transplantat, I-33100 Udine, Italy

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 2023年 / 110卷 / 03期

关键词：

D O I：

10.1111/ejh.13907

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：330 / 331

页数：2

共 7 条

[1] BCR-ABL1 doubling times more reliably assess the dynamics of CML relapse compared with the BCR-ABL1 fold rise: implications for monitoring and management [J].

Branford, Susan ;

Yeung, David T. ;

Prime, Jodi A. ;

Choi, Soo-Young ;

Bang, Ju-hee ;

Park, Jin Eok ;

Kim, Dong-Wook ;

Ross, David M. ;

Hughes, Timothy P. .

BLOOD, 2012, 119 (18) :4264-4271

[2] BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the "GRUPPO TRIVENETO LMC" [J].

Di Giusto, Sara ;

Toffoletti, Eleonora ;

Bonifacio, Massimiliano ;

Binotto, Gianni ;

Miggiano, Maria Cristina ;

Calistri, Elisabetta ;

Stulle, Manuela ;

Ermacora, Anna ;

Stella, Rossella ;

Scaffidi, Luigi ;

D'Amore, Fabio ;

Scotton, Giorgia ;

Griguolo, Davide ;

De Matteis, Giovanna ;

Bertorelle, Roberta ;

Krampera, Mauro ;

Semenzato, Gianpietro ;

Fanin, Renato ;

Damiani, Daniela ;

Tiribelli, Mario .

CANCER MEDICINE, 2023, 12 (03) :3180-3184

[3] Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors [J].

Haddad, Fadi G. ;

Sasaki, Koji ;

Issa, Ghayas C. ;

Garcia-Manero, Guillermo ;

Ravandi, Farhad ;

Kadia, Tapan ;

Cortes, Jorge ;

Konopleva, Marina ;

Pemmaraju, Naveen ;

Alvarado, Yesid ;

Yilmaz, Musa ;

Borthakur, Gautam ;

DiNardo, Courtney ;

Jain, Nitin ;

Daver, Naval ;

Short, Nicholas J. ;

Jabbour, Elias ;

Kantarjian, Hagop .

AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) :856-864

[4] European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia [J].

Hochhaus, A. ;

Baccarani, M. ;

Silver, R. T. ;

Schiffer, C. ;

Apperley, J. F. ;

Cervantes, F. ;

Clark, R. E. ;

Cortes, J. E. ;

Deininger, M. W. ;

Guilhot, F. ;

Hjorth-Hansen, H. ;

Hughes, T. P. ;

Janssen, J. J. W. M. ;

Kantarjian, H. M. ;

Kim, D. W. ;

Larson, R. A. ;

Lipton, J. H. ;

Mahon, F. X. ;

Mayer, J. ;

Nicolini, F. ;

Niederwieser, D. ;

Pane, F. ;

Radich, J. P. ;

Rea, D. ;

Richter, J. ;

Rosti, G. ;

Rousselot, P. ;

Saglio, G. ;

Saussele, S. ;

Soverini, S. ;

Steegmann, J. L. ;

Turkina, A. ;

Zaritskey, A. ;

Hehlmann, R. .

LEUKEMIA, 2020, 34 (04) :966-984

[5] BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase [J].

Hwan Kim, Dennis Dong ;

Simon Kim, Taehyung ;

Atenafu, Eshetu G. ;

Novitzky Basso, Igor ;

Forrest, Donna ;

Bence-Bruckler, Isabelle ;

Savoie, Lynn ;

Busque, Lambert ;

Keating, Mary-Margaret ;

Delage, Robert ;

Xenocostas, Anargyros ;

Liew, Elena ;

Paulson, Kristjan ;

Stockley, Tracy ;

Laneuville, Pierre ;

Lipton, Jeffrey H. ;

Kamel-Reid, Suzanne ;

Leber, Brian .

BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (01) :136-145

[6] Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease [J].

Rousselot, Philippe ;

Charbonnier, Aude ;

Cony-Makhoul, Pascale ;

Agape, Philippe ;

Nicolini, Franck E. ;

Varet, Bruno ;

Gardembas, Martine ;

Etienne, Gabriel ;

Rea, Delphine ;

Roy, Lydia ;

Escoffre-Barbe, Martine ;

Guerci-Bresler, Agnes ;

Tulliez, Michel ;

Prost, Stephane ;

Spentchian, Marc ;

Cayuela, Jean Michel ;

Reiffers, Josy ;

Chomel, Jean Claude ;

Turhan, Ali ;

Guilhot, Joelle ;

Guilhot, Francois ;

Mahon, Francois-Xavier .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (05) :424-U59

[7] Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission [J].

Shanmuganathan, Naranie ;

Braley, Jodi A. ;

Yong, Agnes S. M. ;

Hiwase, Devendra K. ;

Yeung, David T. ;

Ross, David M. ;

Hughes, Timothy P. ;

Branford, Susan .

BLOOD, 2019, 134 (01) :85-89

← 1 →